Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19
Hyundai Bioscience announced that CNPharm, its major shareholding biotech company, has succeeded in developing 'Poly-COV01,' an injection drug for the potential treatment of patients ...
Dec 23